Semaglutide
Semaglutide is commonly sold under brand names such as Ozempic, Wegovy, and Rybelsus.
Semaglutide is a medication used primarily for the management of type 2 diabetes and for chronic weight management in adults with obesity. It is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the effects of incretin hormones, which play a key role in glucose metabolism. Semaglutide enhances insulin secretion in response to elevated blood glucose levels, inhibits glucagon release, slows gastric emptying, and increases feelings of fullness, leading to improved glycemic control and weight loss.Tablets & Capsules
Control Your Blood Sugar
Heart Healthy
100% Authentic
Our Inventory
Image | Name | Type | Strength | Manufacturer | Contact Us |
 | Ozempic | Injection | 1.5ml cartridge, 3ml cartridge 1.34mg/ml | Novo Nordisk Pharma | |
 | Semaslim | Injection | 0.25ml/0.5ml injection 0.25 mg pre-filled syringe | Beacon Pharmaceuticals | |
 | Semaslim | Injection | 0.5ml/0.5ml injection 0.5 mg pre-filled syringe | Beacon Pharmaceuticals | |
 | Semaslim | Injection | 1ml/0.5ml injection 1 mg pre-filled syringe | Beacon Pharmaceuticals |
Featured Semaglutide Generics
Directions
For Type 2 Diabetes, the starting dose is typically 0.25 mg once weekly for the first four weeks. This may be increased to 0.5 mg once weekly, and then further increased to a maximum of 1 mg or higher based on individual needs.
For Chronic Weight Management (Wegovy formulation), the starting dose is 0.25 mg once weekly for the first month, increasing to 0.5 mg, then to 1 mg, and finally up to 2.4 mg once weekly based on tolerance and response. Semaglutide is administered as a subcutaneous injection in the abdomen, thigh, or upper arm. It can be taken with or without food.
Special Precautions
- Pancreatitis Risk: There have been reports of pancreatitis associated with GLP-1 receptor agonists. Patients should be monitored for symptoms such as severe abdominal pain.
- Renal Impairment: Use caution in patients with renal impairment; monitor kidney function regularly.
- Thyroid Tumors: Semaglutide has been associated with an increased risk of thyroid C-cell tumors in animal studies. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
- Pregnancy and Lactation: Consult a healthcare provider if pregnant, planning to become pregnant, or breastfeeding, as the safety of semaglutide during these periods has not been fully established.
- Allergic Reactions: Be aware of potential allergic reactions, including skin rashes or swelling.
Side Effects
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
Serious side effects can include:
- Pancreatitis (e.g., severe abdominal pain)
- Allergic reactions (e.g., rash, itching, swelling)
- Kidney problems (e.g., changes in urination)
Missed Dosage
If a dose is missed, take it as soon as remembered within the same week. If it is almost time for the next dose, skip the missed dose—do not double up to make up for a missed dose.
Storage Requirements
Store semaglutide in the refrigerator (between 2°C to 8°C or 36°F to 46°F) until ready for use. It can be kept at room temperature (up to 30°C or 86°F) for up to 28 days after first use. Keep away from moisture and direct light. Ensure it is out of reach of children and pets.